Apyx Medical Inc (BOV) Stock Price & News

All values in USD	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	12,88 m	19,16 m	12,49 m	13,88 m
Cost of goods sold	4,58 m	7,16 m	4,56 m	5,01 m
Cost of revenue	4,58 m	7,16 m	4,56 m	5,01 m
Research and development expenses	801,00 k	944,00 k	765,00 k	793,00 k
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	8,33 m	11,04 m	8,07 m	9,88 m
Operating expense	9,13 m	11,99 m	8,84 m	10,68 m
Total operating expenses	13,71 m	19,15 m	13,40 m	15,69 m
Operating income	-832,00 k	11,00 k	-911,00 k	-1,81 m
Other non operating income	76,00 k	16,00 k	36,00 k	2,00 k
EBT including unusual items	-1,88 m	-1,15 m	-2,00 m	-2,95 m
EBT excluding unusual items	-1,88 m	-1,15 m	-2,00 m	-2,95 m
Income tax expense	78,00 k	94,00 k	143,00 k	124,00 k
Effective tax rate	-4,16%	-8,20%	-7,15%	-4,21%
Other operating expenses	-	-	-	-
Net income	-1,98 m	-1,30 m	-2,11 m	-3,24 m
Net profit margin	-15,41%	-6,78%	-16,88%	-23,36%
Earnings per share	-0,05	-0,03	-0,05	-0,07
Interest and investment income	292,00 k	234,00 k	244,00 k	250,00 k
Interest expense	-1,41 m	-1,41 m	-1,37 m	-1,39 m
Net interest expenses	-1,12 m	-1,17 m	-1,12 m	-1,14 m
Depreciation and amortization charges	-	-	-	-
EBITDA	-668,00 k	232,00 k	-709,00 k	-1,61 m
Gain or loss from assets sale	19,00 k	-	-	-

Ask anything